Adjuvant Capecitabine for Early Breast Cancer: 15-Year Overall Survival Results From a Randomized Trial.

Heikki Joensuu Pirkko Liisa Kellokumpu-LehtinenRiikka HuovinenArja JukkolaMinna TannerJohan Ahlgren Päivi AuvinenOuti LahdenperäKenneth VillmanPaul NyandotoGreger NilssonPaula Poikonen-Saksela Vesa Kataja Petri Bono Jouni J T Junnila Henrik Lindman

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)

Addition of capecitabine to a chemotherapy regimen that contained docetaxel, epirubicin, and cyclophosphamide prolonged the survival of patients with early breast cancer.

Keyphrases

early breast cancer
locally advanced
rectal cancer
phase ii study
squamous cell carcinoma
free survival
metastatic breast cancer
radiation therapy
early stage
metastatic colorectal cancer
low dose
phase iii
high dose
clinical trial
study protocol